BioScience

Baxter BioScience is one of the leaders in the biotechnology industry and a pioneer in developing critical therapies to treat chronic diseases.

Our portfolio of therapies include:

• Plasma-based and recombinant clotting factors for haemophilia
• Biopharmaceuticals used to treat immune deficiencies and other blood-related disorders
• Vaccines for the prevention of infectious diseases
• BioSurgery products used for haemostasis, tissue-sealing and adhesion prevention in surgery.
  
  

The antibody therapy and critical care business encompass a broad portfolio of specialist blood plasma derived products. These products offer life saving treatments for people, such as those with immune disorders or those requiring critical care. The main treatments include:

Anti-D (Rho) immunoglobulin for intravenous administration
Anti-D (Rho) immunoglobulin for intramuscular administration
Normal immunoglobulin for intravenous administration
Normal immunoglobulin for subcutaneous and intramuscular administration
Human albumin (5% & 20% concentration) for intravenous administration
Protein C concentrate for intravenous administration

Baxter is dedicated to making a contribution to the improvement of public health worldwide. The technologies in which Baxter has special expertise - polysaccharide carrier protein conjugation, recombinant expressions systems and cell culture - have the potential to open the door to a whole new generation of vaccines, both bacterial and viral.

Baxter is using cell-based technology, rather than traditional egg cultured techniques, to develop vaccines for new strains of influenza. Vaccines manufactured using cell-based technology can be available in 12 weeks from provision of the seed virus, which is shorter that the 20-28 weeks taken using traditional methods.

With its state of the art research centre in Austria, Baxter is dedicated to the prevention of a broad spectrum of infectious diseases in infants, children and adults.

Advanced Vaccines for a Healthier Future.

Baxter produces and distributes an expanding range of products that are adjuncts to traditional methods and aid the surgeon in a variety of ways including preventing surgical adhesions, attaining haemostasis and tissue sealing. These products are all biocompatible and are completely resorbed by the body as part of the normal physiological wound healing process.